Modified BEAM as a conditioning regimen for mantle cell lymphoma patients undergoing autologous hematopoietic stem cell transplantation

IF 3.4 3区医学 Q2 HEMATOLOGY Therapeutic Advances in Hematology Pub Date : 2024-05-17 DOI:10.1177/20406207241251541

Piero Galieni, Sadia Falcioni, Emanuela Troiani, Paola Picardi, Catia Bigazzi, Denise Maravalle, Federica De Giorgi, Roberta Taborro, Stefano Angelini

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

将改良 BEAM 作为接受自体造血干细胞移植的套细胞淋巴瘤患者的调理方案

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Therapeutic Advances in Hematology HEMATOLOGY-

CiteScore

4.30

自引率

0.00%

发文量

审稿时长

7 weeks

期刊介绍： Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.

期刊最新文献

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study. Long-term risks of cardiovascular-specific mortality among myeloproliferative neoplasms patients. Clinical features and treatment of newly diagnosed multiple myeloma with secondary myelofibrosis: a retrospective study. Real-world efficacy of chidamide plus R-CHOP in newly diagnosed double-expressor diffuse large B-cell lymphoma. Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment.